About 40% of all men will develop prostate cancer during their lifetime, with over 65,000 new cases diagnosed annually in Germany [1]. Age is a key risk factor, as most cases occur in men aged 65 or older.

“With robot-guided stereotactic radiosurgery (SBRT), we are now able to treat localized prostate cancer – especially intermediate-risk cases – very effectively in many patients,” says Alexander Muacevic, MD, Director of the European Radiosurgery Center Munich (ERCM).

The completed HYPOSTAT-II trial, involving 464 participants – 249 of whom were treated at the ERCM – confirms that SBRT is well tolerated and associated with high patient satisfaction. Results to date are comparable to those of the PACE trials, whose findings contributed to the inclusion of radiosurgery in the German S3 clinical guidelines (the highest level of evidence-based medical guidelines in Germany) in 2025.

Integrating 3D printing technology has emerged as a game-changer in the healthcare system, enhancing workflow and treatment quality.

The Division of Medical Physics at Stanford has led the charge in this area with a dedicated faculty team developing innovative solutions that address longstanding challenges in radiation therapy.

The 2025 Global Radiotherapy Impact Report brings together leading experts from across radiation oncology, including voices well-known to the RSS community, to highlight how advanced radiotherapy, including SBRT and SRS, is transforming cancer care worldwide. Convened by Elekta, the report illustrates compelling clinical outcomes, patient quality of life, and the growing evidence behind high-precision, adaptive, and ablative treatments. It also underscores an urgent truth: expanding access to radiotherapy could save up to 1 million lives each year. RSS members can use this report to stay informed, advocate, and advance the future of precision radiation medicine.

More than 300 people came together for the Leksell Gamma Knife Society Meeting in Stockholm from October 19-21, 2025, chaired by this year's Scientific President Dr Veronica Chiang, director of the Gamma Knife Center at Yale New Haven Hospital. Innovators, scientists, and clinicians from more than 45 countries participated in three days of learning and networking to discuss the future of radiosurgery. The topics covered ranged from Biologically Effective Dose (BED) and AI applications to immobilization techniques and indication-specific deep dives. The future looks promising, especially with five individuals receiving the Young Investigator Award for their outstanding abstracts in various categories. Combining science and technology with passion for people to live longer, this incredible event builds on the momentum to shape the next 50 years of radiosurgery.

This year, this dedicated and pioneering community also celebrated that together they have treated more than two million patients with Leksell Gamma Knife. Read more at the link provided.